The use of human cord blood in regenerative medicine has greatly advanced during the past two decades, said Colin McGuckin, president and director of Cell Therapy Research Institute in France. Cord blood can now treat 85 diseases, including sickle cell anemia and thalassemia, and is also being tested for treating diabetes, stroke and cerebral palsy, McGuckin said.

Related Summaries